Ion channels in genetic epilepsy: from genes and mechanisms to disease-targeted therapies

J Oyrer, S Maljevic, IE Scheffer, SF Berkovic… - Pharmacological …, 2018 - ASPET
Epilepsy is a common and serious neurologic disease with a strong genetic component.
Genetic studies have identified an increasing collection of disease-causing genes. The …

Epilepsy-related voltage-gated sodium channelopathies: a review

LFS Menezes, EF Sabiá Júnior, DV Tibery… - Frontiers in …, 2020 - frontiersin.org
Epilepsy is a disease characterized by abnormal brain activity and a predisposition to
generate epileptic seizures, leading to neurobiological, cognitive, psychological, social, and …

Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders

M Wolff, KM Johannesen, UBS Hedrich, S Masnada… - Brain, 2017 - academic.oup.com
Mutations in SCN2A, a gene encoding the voltage-gated sodium channel Nav1. 2, have
been associated with a spectrum of epilepsies and neurodevelopmental disorders. Here, we …

4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2-encephalopathy

UBS Hedrich, S Lauxmann, M Wolff… - Science translational …, 2021 - science.org
Developmental and epileptic encephalopathies are devastating disorders characterized by
epilepsy, intellectual disability, and other neuropsychiatric symptoms, for which available …

Epilepsy and developmental disorders: Next generation sequencing in the clinic

JD Symonds, A McTague - European Journal of Paediatric Neurology, 2020 - Elsevier
Abstract Background The advent of Next Generation Sequencing (NGS) has led to a
redefining of the genetic landscape of the epilepsies. Hundreds of single gene epilepsies …

Diagnostic targeted resequencing in 349 patients with drug‐resistant pediatric epilepsies identifies causative mutations in 30 different genes

E Parrini, C Marini, D Mei, A Galuppi, E Cellini… - Human …, 2017 - Wiley Online Library
Targeted resequencing gene panels are used in the diagnostic setting to identify gene
defects in epilepsy. We performed targeted resequencing using a 30‐genes panel and a 95 …

Clinical spectrum and genotype–phenotype associations of KCNA2-related encephalopathies

S Masnada, UBS Hedrich, E Gardella, J Schubert… - Brain, 2017 - academic.oup.com
Recently, de novo mutations in the gene KCNA2, causing either a dominant-negative loss-of-
function or a gain-of-function of the voltage-gated K+ channel Kv1. 2, were described to …

Phenotypic spectrum and genetics of SCN2A‐related disorders, treatment options, and outcomes in epilepsy and beyond

M Wolff, A Brunklaus, SM Zuberi - Epilepsia, 2019 - Wiley Online Library
Pathogenic variants in the SCN 2A gene are associated with a variety of
neurodevelopmental phenotypes, defined in recent years through multicenter collaboration …

[HTML][HTML] Distinct roles of GRIN2A and GRIN2B variants in neurological conditions

SJ Myers, H Yuan, JQ Kang, FCK Tan… - …, 2019 - ncbi.nlm.nih.gov
Rapid advances in sequencing technology have led to an explosive increase in the number
of genetic variants identified in patients with neurological disease and have also enabled …

De novo mutations and rare variants occurring in NMDA receptors

W XiangWei, Y Jiang, H Yuan - Current opinion in physiology, 2018 - Elsevier
Highlights•NMDAR rare variants are associated with various neuropsychiatric
disorders.•Functional consequences of variants differ among domains.•Evaluation of …